BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36033827)

  • 1. miR-657 Targets SRCIN1 via the Slug Pathway to Promote NSCLC Tumor Growth and EMT Induction.
    Zhang Y; Yuan J; Guo M; Xiang R; Wang X; Xie T; Zhuang X; Li Q; Lai Q
    Dis Markers; 2022; 2022():4842454. PubMed ID: 36033827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-374a promotes pancreatic cancer cell proliferation and epithelial to mesenchymal transition by targeting SRCIN1.
    Ma L; Shao Z; Zhao Y
    Pathol Res Pract; 2019 Jun; 215(6):152382. PubMed ID: 30890278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXD3-AS1 suppresses the progression of non-small cell lung cancer by regulating miR-150/SRCIN1axis.
    Ji T; Zhang Y; Wang Z; Hou Z; Gao X; Zhang X
    Cancer Biomark; 2020; 29(3):417-427. PubMed ID: 32924985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-211 promotes non-small cell lung cancer proliferation by targeting SRCIN1.
    Ye L; Wang H; Liu B
    Tumour Biol; 2016 Jan; 37(1):1151-7. PubMed ID: 26277787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-17-5p promotes proliferation and epithelial-mesenchymal transition in human osteosarcoma cells by targeting SRC kinase signaling inhibitor 1.
    Zhao X; Xu Y; Sun X; Ma Y; Zhang Y; Wang Y; Guan H; Jia Z; Li Y; Wang Y
    J Cell Biochem; 2019 Apr; 120(4):5495-5504. PubMed ID: 30302813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
    Pang L; Cheng Y; Zou S; Song J
    Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-150-5p promotes the proliferation and epithelial-mesenchymal transition of cervical carcinoma cells via targeting SRCIN1.
    Zhu J; Han S
    Pathol Res Pract; 2019 Apr; 215(4):738-747. PubMed ID: 30679084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-942 promotes tumor migration, invasion, and angiogenesis by regulating EMT via BARX2 in non-small-cell lung cancer.
    Yang F; Shao C; Wei K; Jing X; Qin Z; Shi Y; Shu Y; Shen H
    J Cell Physiol; 2019 Dec; 234(12):23596-23607. PubMed ID: 31236953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus promotes proliferation and metastasis in male Chinese hepatocellular carcinoma patients through the LEF-1/miR-371a-5p/SRCIN1/pleiotrophin/Slug pathway.
    Bai PS; Hou P; Kong Y
    Exp Cell Res; 2018 Sep; 370(1):174-188. PubMed ID: 29928866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SRCIN1 Regulated by circCCDC66/miR-211 Is Upregulated and Promotes Cell Proliferation in Non-Small-Cell Lung Cancer.
    Hong W; Yu S; Zhuang Y; Zhang Q; Wang J; Gao X
    Biomed Res Int; 2020; 2020():5307641. PubMed ID: 32964035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1.
    Cao M; Hou D; Liang H; Gong F; Wang Y; Yan X; Jiang X; Wang C; Zhang J; Zen K; Zhang CY; Chen X
    Eur J Cancer; 2014 Mar; 50(5):1013-24. PubMed ID: 24456795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-373 Inhibits Cell Proliferation and Invasion via Targeting BRF2 in Human Non-small Cell Lung Cancer A549 Cell Line.
    Wang L; Qu J; Zhou L; Liao F; Wang J
    Cancer Res Treat; 2018 Jul; 50(3):936-949. PubMed ID: 29025258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 16. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R; Hu T; Liu Y; He Y; Cao Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-598 Suppresses Invasion and Migration by Negative Regulation of Derlin-1 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
    Yang F; Wei K; Qin Z; Liu W; Shao C; Wang C; Ma L; Xie M; Shu Y; Shen H
    Cell Physiol Biochem; 2018; 47(1):245-256. PubMed ID: 29768262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1.
    Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
    Cell Physiol Biochem; 2018; 46(1):93-106. PubMed ID: 29587281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
    Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C
    J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB; Yang K; Yu HY; Liu M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.